Latest / U.S. Right to Know articles
Pharma bribery corrupts health care, puts patients at risk, new review warns
Sham clinical studies, slush funds, luxury gifts, and shell companies: A new review shows how pharma firms allegedly bribed their way to drug approvals and sales.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.